Visual Electrophysiology Market Outlook

The visual electrophysiology market is anticipated to flourish at a steady CAGR of 7.0% between 2023 and 2033. The market is expected to hold a market share of USD 458.9 million by 2033 while the market is likely to reach a value of USD 234.1 million in 2023.

New technology, materials, and techniques to produce innovative practice solutions significantly contribute to global market growth. In addition to this, the ease of handling visual electrophysiology devices is surging its adoption in home and alternate care settings.

There is spreading awareness of the requirement for occasional eye examinations for early diagnosis of visual disorders. Therefore retinal electrophysiology is expected to surge the demand for visual electrophysiology.

The market size is expected to increase due to the device’s portability and frequent technological advances. The versatility of visual electrophysiology devices for use on adults, children, or animals of all sizes for clinical and research purposes propels its demand.

Attributes Details
Visual Electrophysiology Market CAGR (2023 to 2033) 7.0%
Visual Electrophysiology Market Size (2023) USD 234.1 million
Visual Electrophysiology Market Size (2033) USD 458.9 million

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How is the Technological Influence on the Visual Electrophysiology Market?

Rising technological developments and increasing investments in visual electrophysiology devices are expected to boost market growth. Furthermore, the increasing geriatric population in various parts of the world surges the demand for visual electrophysiology.

Rising expenditures in healthcare advancements and growing adoption practice for visual electrophysiology diagnosis are likely to expand the market size. Moreover, the rising prevalence of neurological and eye disorders are key factors that drive the market growth.

Influx funding for research studies, government initiatives, and awareness programs are growing awareness of the benefits of visual electrophysiology. Additionally, using an electroretinogram (ERG) to eliminate any ophthalmic diseases and establishing correct diagnoses are likely to drive the visual electrophysiology adoption trends.

How are High Costs Impacting the Visual Electrophysiology Market?

High costs associated with the diagnosis and treatment procedures, along with the lack of experience in using advanced technologies, pose a threat to this market. Moreover, rigid regulations by the government for recording electrical signals in the electrophysiological test are further expected to hinder market growth.

The absence of skilled professionals and the availability of property healthcare infrastructure in developing economies might hamper the visual electrophysiology market.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Future Trends for the Visual Electrophysiology Market?

Growing awareness about the adverse effects of visual and neurological disorders is likely to generate revenue opportunities for the market. Furthermore, increasing research and development (R&D) activities, and technological developments, are expected to accelerate market growth.

Modernization in healthcare devices creates significant opportunities for the market. Additionally, the increasing funding by various governments worldwide is expected to provide growth opportunities. It is important to note that authorities across the world are conducting awareness programs regarding such kinds of tests. This is expected to change the visual electrophysiology market outlook.

Country-wise Insights

Countries Revenue Share % (2022)
The United States 33.4%
Germany 5.3%
Japan 3.9%
North America 36.1%
Europe 25.9%
Countries CAGR % (2023 to 2033)
China 8.4%
India 7.1%
The United Kingdom 5.4%
Australia 5.7%

North America Market Growth

North America holds a notable share of the visual electrophysiology market with a significant revenue of 33%. During the forecast period, the market share is anticipated to expand. This is because of the increasing investments being made in research and development in the region.

There have been increasing cases of eye-related disorders in the region, which is expected to surge the market growth of visual electrophysiology further. Moreover, the ability to be used across age groups is expected to drive this market.

Europe Market Growth

Europe’s visual electrophysiology market held a market share of 25.9% in 2022. Increasing cases of cancer in the region are expected to fuel the growth of the market. Moreover, the rapid advancements in technology are expected to further the rise of this market.

The government in this region is proactive when it comes to dealing with the physical well-being of the population. Therefore, awareness programs are expected to shape the visual electrophysiology market trends in the region.

Asia Pacific Market Growth

Asia Pacific is a growing visual electrophysiology market. Improvement of healthcare facilities and economic conditions are likely to surge the market growth.

Japan is also likely to hold a significant market share, owing to the presence of a technologically developed structure. The growing awareness about the importance of eye health is anticipated to bolster the visual electrophysiology market share, in this region. In Asia Pacific as well, increasing investments are being made in research and development, which is expected to drive the market.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-based Analysis

Category By Test Type
Leading Segment Electroretinogram (ERG)
Market Share% (2022) 38.80%
Category By Modality
Leading Segment Fixed
Market Share% (2022) 65.90%

Based on test type, the electroretinogram segment leads the market as it held a market share of 38.80% in 2022. On the other side, the modality category is led by the fixed type segment due to the high consumption. The segment held a market share of 65.90% in 2022.

How is the Start-Up Ecosystem in the Visual Electrophysiology Market?

The ability to locate problems at the early stage and to eliminate specific conditions are increasing the popularity of visual electrophysiology. The startups are offering training to cover recent information on new technology, materials, and techniques for innovative practice solutions. Moreover, certain start-up companies are using traditional methods combined with substantial research and development (R&D) activities. For example,

  • LumiThera Inc. is a medical device start-up company in the visual electrophysiology market. They aim to be at the forefront of the development of photo-biomodulation (PBM) treatment protocols for patients with dry “Age-related macular degeneration” (AMD), which is the leading cause of blindness in adults over 65. They further develop treatments to preserve and improve vision, PBM devices to treat ocular diseases and disorders, learn about the science supporting the use of PBM as well as enquire about ongoing clinical studies.

Competitive Landscape

How is the Competitive Landscape in the Visual Electrophysiology Market?

The extensive range of applications including diagnosis, elimination of specific conditions, locating problems at some level of the visual system, etc. is driving key players to improve devices for visual electrophysiology. This is done through research and development (R&D) activities, for clinical and research purposes.

Recent Developments

  • In October 2017, LKC Technologies announced the revolutionary RETeval Device’s latest software release (2.8.0), which includes age-adjusted normative data and is available for human use.
  • In September 2020, Konan Medical (Japan) and Konan Medical USA Inc., announced the launch of a new endothelial imaging system called ‘CellChek 20’, which adds a single-button press exam that acquires images of both eyes and automated analysis with the new, fully-automated Center Method.
  • In June 2022, NICE published the final draft guidance recommending a new drug called “Faricimab” to help treat two leading causes of sight loss and visual impairment
  • MetroVision has introduced its model MonPackOne with a compact stimulator, luminance-controlled LED, near-infrared cameras, and one compressed recording camera.
  • Konan Medical USA has also launched its Visual Electrophysiology System, named EvokeDx which works on icVEP, VEP, and pERG platforms.

Key Players Operating in the Global Market

  • MetroVision
  • Konan Medical USA
  • Diopsys Inc
  • Nationwide Children’s Hospital
  • The Royal College of Ophthalmologists
  • LKC Technologies Inc.
  • Boston Scientific Corporation
  • Abbott
  • Biosense Webster Inc.
  • Biotronik
  • General Electric Company
  • Siemens Healthcare GmbH
  • MicroPort Scientific Corporation
  • Koninklijke Philips N.V.
  • NIHON KOHDEN CORPORATION
  • CardioFocus
  • Stereotaxis Inc.
  • Molecular Devices LLC

Key Segments Covered

By Test Type:

  • Electroretinogram (ERG)
  • Multifocal Electroretinogram (mfERG)
  • Electro-Oculogram (EOG)
  • Visual-Evoked Responses (VER)

By Modality:

  • Fixed
  • Portable

By End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers

Key Region:

  • North America
    • The United States
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • The United Kingdom
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Japan
  • Asia Pacific Excluding Japan
    • China
    • India
    • Malaysia
    • Singapore
    • Australia
    • Rest of Asia Pacific Excluding Japan (APEJ)
  • Middle East and Africa
    • GCC Countries
    • Israel
    • South Africa
    • The Middle East and Africa (MEA)

Frequently Asked Questions

What is China’s Visual Electrophysiology Market CAGR?

The market in China is expected to record a CAGR of 8.4% through 2033.

Who are the Prominent Visual Electrophysiology Market Players?

Abbott, Biosense Webster Inc., Biotronik are the prominent market players.

What is the Growth Forecast for the Visual Electrophysiology Market?

The industry is forecast to record a CAGR of 7.0% through 2033.

What is the Industry Valuation by 2033?

The industry is expected to reach USD 458.9 million by 2033.

What was the Share of Europe’s Visual Electrophysiology Market in 2022?

Europe’s visual electrophysiology market held a market share of 25.9% in 2022.

Table of Content
	1. Executive Summary
	2. Market Overview
	3. Market Background
	4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
	5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type
		5.1. Electroretinogram (ERG)
		5.2. Multifocal Electroretinogram (mfERG)
		5.3. Electro-Oculogram (EOG)
		5.4. Visual-Evoked Responses (VER)
	6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Modality
		6.1. Fixed
		6.2. Portable
	7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
		7.1. Hospitals
		7.2. Clinics
		7.3. Ambulatory Surgical Centers
		7.4. Diagnostic Imaging Centers
	8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
		8.1. North America
		8.2. Latin America
		8.3. Western Europe
		8.4. Eastern Europe
		8.5. South Asia and Pacific
		8.6. East Asia
		8.7. Middle East and Africa
	9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
	10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
	11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
	12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
	13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
	14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
	15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
	16. Key Countries Market Analysis
	17. Market Structure Analysis
	18. Competition Analysis
		18.1. Metrovision
		18.2. Konan Medical USA
		18.3. Diopsys Inc
		18.4. Nationwide Children’s Hospital
		18.5. The Royal College of Ophthalmologists
		18.6. LKC Technologies Inc.
		18.7. Boston Scientific Corporation
		18.8. Abbott
		18.9. Biosense Webster Inc.
		18.10. Biotronik
		18.11. General Electric Company
		18.12. Siemens Healthcare GmbH
		18.13. MicroPort Scientific Corporation
		18.14. Koninklijke Philips N.V.
		18.15. NIHON KOHDEN CORPORATION
		18.16. CardioFocus
		18.17. Stereotaxis Inc.
		18.18. Molecular Devices LLC
	19. Assumptions & Acronyms Used
	20. Research Methodology
Recommendations

Healthcare

Arthroscopy Visualization Systems Market

October 2022

REP-GB-15735

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Visual Electrophysiology Market

Schedule a Call